Destructive management of skin cancers in organ transplant recipients

Cancer Treatment and Research

Volumn 146, Issue , 2009, Pages 447-460

  Ng, Jonathan ^a   Chong, Alvin ^b   Foley, Peter ^b  

^a SKIN AND CANCER FOUNDATION   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYACID; AMINOLEVULINIC ACID METHYL ESTER; BETA HYDROXYACID; FLUOROURACIL; HYDROXYACID; IMMUNOMODULATING AGENT; TRICHLOROACETIC ACID; UNCLASSIFIED DRUG;

ACTINIC KERATOSIS; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER RECURRENCE; CARBON DIOXIDE LASER; CHEMOSURGERY; CLINICAL TRIAL; CRYOSURGERY; CRYOTHERAPY; DIATHERMY; ELECTROSURGERY; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; INTERMETHOD COMPARISON; KERATOACANTHOMA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; SKIN ABRASION; SKIN BIOPSY; SKIN CANCER; SKIN CURETTAGE; SKIN ELECTRODESSICATION; SKIN SURGERY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR VOLUME; BOWEN'S DISEASE; CARCINOMA, SQUAMOUS CELL; CURETTAGE; DERMATOLOGY; IMMUNOTHERAPY; KERATOSIS, ACTINIC; ORGAN TRANSPLANTATION; PROCEDURES; SKIN NEOPLASMS;

BOWEN'S DISEASE; CARCINOMA, SQUAMOUS CELL; CRYOTHERAPY; CURETTAGE; DERMATOLOGY; HUMANS; IMMUNOTHERAPY; KERATOACANTHOMA; KERATOSIS, ACTINIC; ORGAN TRANSPLANTATION; SKIN NEOPLASMS;

EID: 77953656968     PISSN: 09273042     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-78574-5_37     Document Type: Review

References (35)

1. Thai KE, Sinclair RD. Crosurgery of benign skin lesions. Australas J Dermatol 1999; 40:175-86.
2. Freeman M, Vinciullo C, Francis D, Spelman L, Nguyen R, Fergin P, Thai KE, Murrell D, Weightman W, Anderson C, Reid C,Watson A, Foley P. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatol Treat 2003; 14:99-106.
3. Thai KE, Fergin P, Freeman M, Vinciullo C, Francis D, Spelman L, Murrell D, Anderson C, Weightman W, Reid C, Watson A, Foley P. A prospective study of the use of cryosurgery for the treatment of actinic keratoses. Int J Dermatol 2004; 43:687-92.
4. Sheridan AT, Dawber RP. Curettage, electrosurgery and skin cancer. Australas J Dermatol 2000; 41:19-30.
5. Goldman G. The current status of curettage and electrodessication. Dermatol Clin 2002; 20:569-78.
6. Clayton AS, Stasko T. Treatment of nonmelanoma skin cancer in organ transplant recipients: review of responses to a survey. J Am Acad Dermatol 2003; 49:413-16.
7. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348:1681-91.
8. Kokozska A, Scheinfeld N. Evidence-based review of the use of cryosurgery in treatment of basal cell carcinoma. Dermatol Surg 2003; 29:566-71.
9. Australian Cancer Network Management of Non-Melanoma Skin CancerWorking Party. Nonmelanoma skin cancer: guidelines for treatment and management in Australia. 2002
10. Thissen M, Nieman F, Ideler A, Berretty P, Neumann H. Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck. Dermatol Surg 2000; 26:759-64.
11. Wang I, Bendsoe N, Klinterberg C, Enejder A, Andersson-Engels S, Svanberg S, et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 2001; 144:832-40.
12. Hall V, Leppard B, McGill J, Kesseler M, White J, Goodwin P. Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy. Clin Radiol 1986; 37:33-4.
13. Basset-Seguin N Ibbotson S, Emtestam L, Tarstedt M, Morton C, Maroti M, et al. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomised trail. Eur J Dermatol 2008; 18:547-53.
14. Kanitakis J, Alhaj-Ibrahim L, Euvrard S, Claudy A. Basal cell carcinomas developing in solid organ transplant recipients: clinicopathologic study of 176 cases. Arch Dermatol 2003; 139:1133-7.
15. Mallon E, Dawber R. Cryosurgery in the treatment of basal cell carcinoma. Dermatol Surg 1996; 22:854-8.
16. Stasko T, Brown MD, Carucci JA et al. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 2004; 30:642-50.
17. Anonymous. European best practice guidelines for renal transplantation. Section IV. Longterm management of the transplant recipient. IV.6.2. Cancer risk after renal transplantation. Skin cancers: prevention and treatment. Nephrol Dial Transplant 2002; 17(Suppl 4): 31-6.
18. Rosenblatt L, Marks R. Deaths due to squamous cell carcinoma in Australia: is there a case for a public health intervention? Australas J Dermatol 1996; 37:26-9.
19. de Graaf YG, Basdew VR, van der Zwan-Kralt N, Willemze R, Bouwes Bavinck JN. The occurrence of residual or recurrent squamous cell carcinomas in organ transplant recipients after curettage and electrodesiccation. Br J Dermatol 2006; 154:493-7.
20. Reymann F. Treatment of multiple squamous cell carcinomas of the skin in an immunosuppressed patient. Dermatologica 1981; 162:304-6.
21. Cooper JZ, Brown MD. Special concern about squamous cell carcinoma of the scalp in organ transplant recipients. Arch Dermatol. 2006; 142(6):755-8.
22. Morton C, Horn M, Leman J, Tack B, Bedane C, Tjioe M, Ibbotson S, Khemis A, Wolf P. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or fluorouracil for treatment of squamous cell carcinoma in situ: results of a multicenter randomized trial. Arch Dermatol 2006; 142(6):729-35.
23. Ball S, Dawber R. Treatment of cutaneous Bowen's disease with particular emphasis on the problem of lower leg lesions. Aust J Dermatol 1998; 39:63-70.
24. HoneycuttWM, Jansen GT. Treatment of squamous cell carcinoma of the skin. Arch Dermatol 1973; 108:670-2.
25. Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47:1-17.
26. Ulrich C, Schmook T, Nindl I,Meyer T, SterryW, Stockfleth E. Cutaneous precancers in organ transplant recipients: an old enemy in a new surrounding. Br J Dermatol 2003; 149(Suppl 66):40-2.
27. Orengo I, Brown T, Rosen T. Cutaneous neoplasia in organ transplant recipients. Curr Probl Dermatol 1999; 11:121-60.
28. Lubritz RR, Smolewski SA. Cryosurgery cure rate of actinic keratoses. J Am Acad Dermatol 1982; 7:631-2.
29. Fraunfelder FT, Farris HEJ, Wallace TR. Cryosurgery for ocular and periocular lesions. J Dermatol Surg Oncol 1977; 3:422-7.
30. Szeimies RM, Karrer S, Radakovic-Fijan S, Tanew A, Calzavara-Pinton PG, Zane C et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 2002; 47(2): 58-62.
31. Ulrich C, Busch JO, Meyer T, Nindl I, Schmook T, Sterry W, Stockfleth E. Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six cases. Br J Dermatol 2006; 155(2):451-4.
32. Traywick C, O'Reilly FM. Management of skin cancer in solid organ transplant recipients. Dermatol Ther 2005; 18:12-8.
33. Holt PJ. Cruotherapy for skin cancer: results over a 5-year period using liquid nitrogen spray cryosurgery. Br J Dermatol 1988; 119:231-40.
34. Nedwich JA. Evaluation of curettage and electrodesiccation in treatment of keratoacanthoma. Australas J Dermatol 1991; 32:137-41.
35. Carucci JA. Squamous cell carcinoma in organ transplant recipients: approach to management. Skin Therapy Lett 2004; 9:5-7.